Skyepharma PLC announces Research Update (Marketwire)

SkyePharma PLC (LSE:SKP.L - The author of the poster, Dr. Ekkehard Beck, stated "Study results suggest that long term treatment with FlutiformTM 100/10?g and FlutiformTM 250/10?g will be a safe therapy for patients with persistent asthma." The results of this trial will form part of the US New... [read full story]                    

Add Comment
There are also 14 related articles
View all news articles about*:
*Newstin tag cloud displays all featured persons, associated organizations, related topics, regions and companies